Global
聯絡我們
DKSH has been recognized as a Great Place to Work® in 16 key markets, surpassing the number of certified markets in the previous year. DKSH has also been named one of the “Fortune 100 Best Companies to Work For™ Southeast Asia 2025”. These achievements reaffirm DKSH’s work environment and underscore its ongoing commitment to fostering a great corporate culture.
DKSH has announced Natale Capri as the sole Head of the Business Unit Performance Materials, building on his more than ten years of experience as Business Unit Co-Head. Thomas Sul, the former Co-Head, will transition into retirement.
DKSH has achieved another milestone in its sustainability efforts, as the Science Based Targets initiative (SBTi) has officially validated its near-term and net zero targets. This approval reflects DKSH’s commitment to its climate ambitions and reinforces its goal of achieving net-zero emissions by 2050.
DKSH has signed an agreement to acquire Biomedic Science Material Joint Stock Company (“Biomedic”), a leading distributor of equipment and reagents used in the biotechnology and diagnostic market in Vietnam. With this transaction, DKSH Technology further extends its scientific solutions business in line with the Business Unit’s strategy to solidify its position as a leading scientific solutions provider in Asia and Beyond.
DKSH announced today that it has signed an agreement to acquire Invita (NZ) Limited in New Zealand and Invita Australia Pty Limited in Australia (“Invita”). With this transaction, DKSH Performance Materials enhances its capabilities in the attractive food and beverage market, particularly in the dairy and nutritional segments, and strengthens its position as a leading life science and industrial specialties distributor in Asia Pacific.
DKSH Holding Ltd. (“DKSH”) has, through its 100%-owned subsidiary DKSH Resources (Malaysia) Sdn Bhd (“DKSH Resources”), today submitted an offer to fully take over its Malaysian subsidiary DKSH Holdings (Malaysia) Berhad (“DHMB”) by taking over the remaining outstanding 25.7% of shares currently held by minority shareholders. As part of DKSH’s ongoing efforts to simplify company structures, DKSH subsequently aims to delist DHMB from the Malaysian stock exchange.
DKSH appoints Patrik Grande as new Head Business Unit Healthcare and new member of the Executive Committee. He follows Bijay Singh who will retire after eleven years at DKSH.
DKSH celebrates its 160th anniversary, tracing its origins back to Japan in 1865. As the oldest foreign company with an uninterrupted presence in Japan, DKSH has contributed to the region’s economic development for over a century. This rich history, combined with the strong Swiss heritage, has shaped DKSH into the company it is today – a trusted partner for businesses seeking to grow in Asia and beyond.
DKSH has been recognized as an “Industry Leader” for its sustainability performance in the 2025 ISS ESG Corporate Rating as the results have increased to B- (from C+). This improvement reflects DKSH’s continued commitment to sustainability, especially highlighting its climate strategy and participation in the Science Based Targets Initiative.
DKSH has closed an agreement to acquire Aston Chemicals Ltd (“Aston Chemicals”), a specialty chemicals and ingredients distributor for the personal care industry, operating in the UK and Poland. Through this acquisition, DKSH Performance Materials expands its footprint in Europe, adding 38 specialists dedicated to the personal care industry in the UK and Poland, and gains additional formulation expertise to deliver more tailored, high-performance solutions to its customers.
DKSH has signed an agreement with the Eppendorf Group, a leading German life science company, to acquire Eppendorf’s direct presence in Thailand. With this transaction, DKSH further solidifies its position as a leading scientific solutions provider in Asia and beyond.
Core EBIT increased by 5.1% (at CER1) to CHF 169.3 million Core EBIT margin expanded by 10 basis points to 3.1% Net sales grew by 2.1% (at CER) to CHF 5.5 billion Five M&A transactions announced in H1 2025 Strong Free Cash Flow of CHF 121.6 million (cash conversion 117.5%) Confirmed outlook for 2025
DKSH has announced today that it signed an agreement to acquire APN Plastics, a specialty polymers distributor, operating in Australia and Malaysia. The acquisition enables DKSH Performance Materials to further scale the presence in both markets based on a diversified client and customer base.
DKSH has been recognized as a Great Place to Work® in multiple key markets. This certification affirms the excellent work environment at DKSH and reflects the ongoing commitment to supporting and empowering its employees. DKSH aims to attain this certification across further markets as part of its continued focus on maintaining a high-performing corporate culture.
DKSH has signed an agreement to acquire Zircon-Swis Fine Foods Pte Ltd (“Zircon-Swis”), a well-established food service distributor in Singapore. With this move, DKSH further expands its food service business with additional cross-selling and scale-up potential in Asia Pacific.
DKSH enters into a partnership with Klimate for carbon dioxide (CO2) removal solutions to further its mission of achieving net-zero operations. In line with the ongoing CO2 emissions reduction initiatives, DKSH will be procuring high-quality, verifiable CO2 removal credits from Klimate.
DKSH’s sustainability efforts have been recognized by EcoVadis with the Gold Medal, placing DKSH among the top 5% of rated companies globally. The improved score highlights DKSH’s continued dedication to sustainability and its proactive approach in advancing responsible business practices.
Shareholders approved all motions with a clear majority Reelection of the current Board members seeking another term as well as the Chairman of the Board of Directors, and appointment of a new Board member Proposal of dividend increase of 4.4% to CHF 2.35 per share accepted
DKSH has signed an agreement to acquire Molecular Diagnostics Korea Inc. (“MDxK”), a well- established player in the South-Korean life-science space. With this transaction, DKSH Technology further extends its scientific solutions business in line with the Business Unit’s strategy to solidify its position as a leading scientific solutions provider in Asia and Beyond.
DKSH has signed an agreement to acquire Taqkey Science (“Taqkey”) and Quantum Biotech (“Quantum”) in Taiwan. With these transactions, DKSH Technology further extends its scientific solutions and consumables businesses in line with the Business Units’ strategy to solidify its position as a leading scientific solutions provider in Asia and Beyond.
DKSH has received Global ISO certifications for environmental practices (ISO 14001) as well as occupational health and safety (ISO 45001) across multiple markets. This achievement reinforces DKSH’s commitment to sustainability and safety in its supply chains, which are continuously improved. DKSH aims to extend these ISO certifications to other key markets in the future.
Net sales reached CHF 11.1 billion (4.0% at CER1) Core EBIT increased to CHF 343.1 (8.4% at CER1) Core EBIT margin expanded by >10 basis points to 3.1% (4th consecutive year) Free Cash Flow of CHF 256.5 million (cash conversion of 113.6%) Dividend proposal of CHF 2.35 per share (+4.4%)2 Mid-term roadmap confirmed
DKSH has closed the acquisition of CLMO TECHNOLOGY SDN BHD (“CLMO”) with business locations in Malaysia and Vietnam. With this transaction, DKSH extends both its Semiconductor & Electronics and Scientific Solutions business lines.
At today’s Capital Markets Day in London, DKSH outlines its mid-term roadmap based on the strategic priorities of growth, margin expansion, and accelerated M&A. The company presents updated Business Unit strategies and at the same time drives sustainability by committing to set a science based target. DKSH reconfirms its outlook for 2024.
DKSH has announced today that it signed an agreement to acquire Euroingredientes in Portugal. The acquisition enables DKSH Performance Materials Portugal to establish a strategic footprint in the food market with a unique product portfolio of food ingredients and nutraceuticals.
Continued value creation in H1 2024 Core EBIT increased by 8.2% (at CER1) to CHF 163.6 million Core EBIT margin expanded by 10 basis points to 3.0% Net sales grew by 3.3% (at CER) to CHF 5.4 billion Consumer Goods Core EBIT margin reached mid-term target of 2.5% Strong Free Cash Flow of CHF 160.8 million (cash conversion 136.0%) Confirmed outlook for 2024 Capital Markets Day on November 18 in London
DKSH has today announced to have signed an agreement to acquire Elite Organic Sdn. Bhd. (Elite Organic) in Malaysia today. With this transaction, DKSH Performance Materials expands its capabilities in the highly attractive pharmaceuticals, foods, and nutraceutical markets, and strengthens its position as a leading specialty chemicals and ingredients distributor in Asia Pacific.
Shareholders approved all motions with a clear majority All current Board members reelected Proposal of dividend increase of 4.7% to CHF 2.25 per share accepted
Net sales reached CHF 11.1 billion (5.3% at CER1) Core EBIT grew to CHF 329.9 million (12.6% at CER1) Core EBIT margin expanded by >15 basis points to 3.0% Free Cash Flow of CHF 282.3 million (cash conversion at 137.0%) Dividend proposal of CHF 2.25 per share (+4.7%)2 Capital Markets Day planned in H2 2024
DKSH has signed an agreement to acquire Medipharm Sdn Bhd (“Medipharm”), one of the leading pharmaceutical and medical devices distributors in Brunei. With this acquisition, DKSH Healthcare grows its business in line with the strategy to expand its footprint in the Asia-Pacific region.
DKSH has signed an agreement to acquire Bio-Strategy Limited (“Bio-Strategy”), the largest independent distributor of scientific instruments in Australia and New Zealand. With this acquisition, DKSH grows its Scientific Instrumentation business in line with Business Unit Technology’s strategy to build resilience and deliver profitable growth.
DKSH has converted its existing CHF 150 million revolving credit facility loan into a sustainability-linked revolving credit facility. This is the second sustainable finance instrument DKSH has entered into within this year, further strengthening its commitment to increase gender diversity in its senior leadership team positions, and become climate neutral (Scope 1+2) by 2030.
DKSH has closed the acquisition of Partizan Worldwide Pty Limited (“Partizan”), a leading patient support healthcare solutions provider in Australia. With this acquisition, DKSH grows its patient services business in line with Business Unit Healthcare’s strategy to expand its market position and drive into higher added value segments and services.
DKSH has announced the acquisition of New Zealand’s leading independent beauty product distributor CS&Co. today. With the acquisition, DKSH Business Unit Consumer Goods strengthens its capabilities in the growing beauty sector in New Zealand.
Net sales increased to CHF 5.6 billion (7.2% at CER1) Core EBIT grew double digit to CHF 162.6 million (15.5% at CER) Core EBIT margin expanded by 15 basis points to 2.9% Free Cash Flow of CHF 179.0 million and strong cash conversion of 168.2% Confirmed outlook for 2023
DKSH has converted its existing CHF 315 million bank loan into a sustainability-linked loan by tying the interest terms to its ambitious sustainability targets. These targets are consistent with DKSH's overall sustainability strategy to increase gender diversity in its senior leadership team and become climate neutral (Scope 1+2) by 2030.
DKSH has published its 2022 Sustainability Report, outlining its revised sustainability strategy and the progress made on environmental, social, and governance-related topics. Alongside, DKSH also publishes its first Task Force on Climate-Related Financial Disclosures (TCFD) Report.
DKSH has completed the migration of SAP S/4HANA, an enterprise resource planning (ERP) software. Enhancing automation, innovation, and future-readiness, the implementation of this solution is in line with DKSH’s digital transformation ambitions.
Shareholders approved all motions with a clear majority All current Board members re-elected Gabriel Baertschi elected as new member of the Board of Directors Proposal of dividend increase of 4.9% to CHF 2.15 per share accepted
EBIT growth of 12.2% to CHF 319.2 million All Business Units improved performance Free Cash Flow of CHF 209.5 million (Cash Conversion 100.6%) Closing of ten acquisitions Dividend proposal of CHF 2.15 per share (+4.9%)3
DKSH has signed an agreement to acquire two pharma brands from Eisai for nine markets in Asia Pacific. The acquisition fits in DKSH's strategy to grow in higher value-added segments and services and solidifies DKSH Healthcare’s leading position in the region.
By successfully completing the acquisition of Terra Firma, a leading distributor of specialty chemicals in North America, DKSH expands its platform of the Business Unit Performance Materials in the USA and Canada.
DKSH has signed an agreement to acquire two ear care brands from Noru Pharma for Australia, New Zealand, and selected markets in Asia. The acquisition is in line with DKSH's strategy to grow in higher value-added segments and services and it expands its Healthcare Own Brands business to 14 markets in Asia Pacific.
DKSH’s commitment to Sustainability has been recognized with the internationally renowned EcoVadis Gold Rating. With its score DKSH ranks among the top 5% of the companies rated by EcoVadis.
DKSH has signed the acquisition of Terra Firma, a leading distributor of specialty chemicals in North America. With this acquisition, DKSH expands its platform of the Business Unit Performance Materials to the USA and Canada. The transaction is an important step in DKSH's strategy to build a global distribution platform for specialty chemicals and ingredients.
EBIT increased by 16.6% to CHF 153.3 million (19.9% at CER¹) driven by all four Business Units EBIT margin expanded by 30 basis points to 2.7% Net sales grew by 2.0% to CHF 5,596.2 million (3.7% at CER¹) RONOC increased by 170 basis points to 20.4% Disciplined strategy and M&A execution (six acquisitions signed) Confirmed outlook for 2022
Today, DKSH has published its 2021 Sustainability Report, showing good progress on its environmental, social, and governance targets. DKSH reduced its total Scope 1 and 2 emissions by 40% in 2021, ahead of the 35% target until 2025. With this, DKSH has announced a new target to reduce 65% of its own greenhouse gas emissions by 2025. Also, DKSH now employs 29% females in senior leadership positions, up from 27% in 2020.
DKSH Business Unit Performance Materials has signed an agreement to acquire Georg Breuer GmbH (GBFI), a German distributor of plant-based ingredients for the food industry. This transaction is in line with DKSH's strategy of growing its European market coverage and expanding its value-added service offering.
DKSH has announced the acquisition of Swiss Refarmed Group today. With this transaction, DKSH Performance Materials significantly expands its capabilities in Active Pharmaceutical Ingredients (APIs) and strengthens its position as a leading Life Sciences distributor.
DKSH Business Unit Healthcare has signed an agreement to acquire Acutest Systems, a Malaysian in-vitro diagnostic provider. The transaction is in line with DKSH's strategy of further expanding in the fragmented medical devices industry in Asia Pacific.
DKSH has joined the United Nations Global Compact initiative, the largest corporate responsibility initiative in the world, further strengthening its commitment to sustainability.
DKSH signs an agreement to acquire DNIV Group, a major player in the semiconductor and electronics distribution segment in Asia. With the acquisition, DKSH strengthens its existing operations.
DKSH has signed an agreement to acquire Victa Food, a specialized distributor of food and nutritional supplements in Italy. The acquisition is in line with DKSH's strategy to expand its specialty chemicals and ingredients business in Europe.
Shareholders approve all motions All Board members re-elected Dividend increase to CHF 2.05 per share approved
DKSH appoints Sam Oh, Chief Information Officer, as new member of the Executive Committee. At the same time, Daniel Culverhouse, currently Head Supply Chain Management, has decided to leave the company for personal reasons.
Net sales increase of 5.4%1 EBIT growth of 10.5% to CHF 284.6 million Profit after tax 39.6% higher than 20203 Free Cash Flow grows by 24.5% to CHF 261.6 million Consistent with progressive dividend policy, dividend 5.1% higher at CHF 2.05 per share4
DKSH has announced today the acquisition of the third-party distribution business of Spanish food and pharmaceutical ingredients producer and distributor HTBA. The transaction is in line with DKSH's strategy to increase its presence in specialty chemicals and ingredients distribution in Europe.
DKSH has signed an agreement to acquire the Australian Field Marketer STP, strengthening its Field Marketing capabilities in Asia Pacific.
DKSH returns to growth with net sales reaching CHF 5.5 billion (+5.3%)¹Consistent strategy implementation results in 20.7% EBIT increase to CHF 131.5 million¹DKSH completes four value-accretive acquisitionsFree Cash Flow doubles compared to H1 2020
By successfully completing the acquisition of Hahn Healthcare, an Australian medical engagement company, DKSH continues its strategy to offer wide market coverage across Asia Pacific and its focus on value-added services and sales force outsourcing.
DKSH expands Business Unit Healthcare by acquiring Hahn Healthcare, an Australian medical engagement company. The transaction supports DKSH's strategy to offer wide market coverage across Asia Pacific and its focus on value-added services and sales force outsourcing.
By successfully completing the acquisition of life sciences distributor Bosung in Korea and medical devices distributor MedWorkz in Singapore, DKSH continues to drive market consolidation and expands its leading positions in Asia Pacific.
Mit dem erfolgreichen Abschluss der Übernahmen des Life Sciences-Distributors Bosung in Korea und des Medizintechnik-Distributors MedWorkz in Singapur treibt DKSH die Marktkonsolidierung weiter voran und baut die führende Position in Asien Pazifik aus.
All proposals of the Board of Directors approvedMarco Gadola confirmed as Chairman and all Board members re-electedShareholders approve dividend rise to CHF 1.95 per share (+2.6%), representing a 2.7% yield¹
Aktionäre genehmigen alle Anträge des VerwaltungsratesMarco Gadola als Verwaltungsratspräsident und alle Verwaltungsratsmitglieder bestätigtAktionäre stimmen Erhöhung der Dividende auf CHF 1.95 pro Aktie (+2.6%) zu, was einer Rendite von 2.7% Rendite entspricht1
DKSH gibt heute zwei Akquisitionen in Asien Pazifik bekannt. Die DKSH Geschäftseinheit Technologie unterzeichnet eine Vereinbarung zur Übernahme von Bosung, einem koreanischen Life Sciences-Distributor, und die DKSH Geschäftseinheit Healthcare erwirbt MedWorkz, einen Medizintechnik-Distributor in Singapur.
DKSH today announced two acquisitions in Asia Pacific. In Business Unit Technology, DKSH signed an agreement to acquire Bosung, a Korean life sciences distributor, and in Business Unit Healthcare, DKSH acquired medical device distributor MedWorkz in Singapore.
DKSH appoints three new members to the Executive Committee. Antoine Mangin (Chief HumanResources Officer), Dan Culverhouse (Head of Supply Chain Management) and Martin Frech (Chief Strategy Officer and Head of eCommerce), will join DKSH's Executive Committee.
DKSH ernennt drei neue Mitglieder in die Geschäftsleitung. Antoine Mangin (Chief HumanResources Officer), Dan Culverhouse (Head of Supply Chain Management) und Martin Frech(Chief Strategy Officer und Head eCommerce) treten der Geschäftsleitung von DKSH bei.
Trotz COVID-19 liegen Kennzahlen zu konstanten Wechselkursen auf VorjahresniveauFast Moving Consumer Goods zum zweiten Jahr in Folge mit EBIT-WachstumStarker Free Cashflow von CHF 210.2 Millionen (+34.1%)Unter Annahme abschwächender COVID-19 Auswirkungen höheres EBIT in 2021 zu erwarten
Despite COVID-19, DKSH reports key figures broadly stable on last year's level – at CER1Second consecutive year of EBIT growth in Fast Moving Consumer GoodsStrong Free Cash Flow of CHF 210.2 million (+34.1%)Assuming an easing of the impact of COVID-19, higher EBIT expected in 2021
As part of their consolidation strategy, Kraft Heinz has appointed DKSH as food services partner in Hong Kong and Macau, solidifying DKSH's position as anchor partner for Kraft Heinz in the region.
Per Februar 2021 übernimmt Sam Oh die Funktion des Chief Information Officer. Verantwortlich für die Weiterentwicklung der gruppenweiten IT-Strategie wird er die digitale Transformation von DKSH beschleunigen.
As of February 2021, Sam Oh will join DKSH as new Chief Information Officer, responsible for further developing the Group-wide IT strategy and accelerating the company's digital transformation.
By integrating specialty chemicals distributor Axieo, DKSH has gained broader market coverage and customer reach in the Asia Pacific region and now assumes a leading role in the Australian and New Zealand markets.
DKSH hält heute den zweiten Investorentag ab und gibt Einblicke in alle Geschäftseinheiten. Das Unternehmen ist gut positioniert, um die Herausforderungen von COVID-19 zu meistern und zukünftiges Wachstum zu generieren. DKSH profitiert dabei von positiven, langfristigen Markttrends, dem robusten Geschäftsmodell sowie der bewährten Strategie.
Today, DKSH holds its second Capital Markets Day and provides insights into all Business Units. DKSH is well positioned to navigate through COVID-19 challenges and has set the stage for future growth ‒ capitalizing on positive, long-term market trends, its resilient business model as well as its proven strategy.
Nettoumsatz auf Vorjahresniveau zu konstanten WechselkursenTrotz COVID-19 liegt EBIT über VorjahrHöherer Free Cashflow und starke BilanzFast Moving Consumer Goods Turnaround führt zu starkem EBIT-WachstumDKSH bleibt langfristig optimistisch für Asien
Net sales at constant exchange rates stable compared to last yearDespite COVID-19, EBIT above last yearHigher Free Cash Flow and robust balance sheetFast Moving Consumer Goods turnaround leads to strong EBIT growthDKSH remains optimistic about Asia's long-term outlook
Mit der Publikation des dritten Nachhaltigkeitsberichts dokumentiert DKSH die Fortschritte in den Bereichen Umwelt, Gesellschaft und Governance. In Einklang mit dem neu definierten Unternehmenszweck “enrich people's lives” setzt DKSH erstmals Nachhaltigkeitsziele.
Today, DKSH has published its third Sustainability Report detailing progress and achievements on environmental, social and governance aspects. Alongside its new purpose to “enrich people's lives”, DKSH commits to sustainability targets for the Group.
Shareholders approve all motions at the Ordinary General MeetingDistribution of CHF 1.90 dividend per share to be made as from May 19, 2020Withdrawal of outlook 2020 due to COVID-19 situationCapital Market Day on September 21, 2020
Aktionäre genehmigen alle Anträge an der ordentlichen GeneralversammlungAusschüttung der Dividende von CHF 1.90 pro Aktie ab 19. Mai 2020Aufgrund von COVID-19 hebt DKSH den Ausblick für 2020 aufInvestorentag am 21. September 2020
DKSH wird die Generalversammlung am 13. Mai 2020 durchführen.
DKSH will hold its General Meeting on May 13, 2020.
DKSH cancels its Ordinary General Meeting on March 19, 2020 and Capital Market Day on May 15, 2020. DKSH intends to hold its General Meeting with the same agenda in the coming months and its Capital Market Day in the second half of 2020.
Die Generalversammlung vom 19. März 2020 sowie der Investorentag vom 15. Mai 2020 finden nicht wie geplant statt. DKSH beabsichtigt, die Generalversammlung in den nächsten Monaten mit den ursprünglichen Traktanden einzuberufen und den Investorentag im 2. Halbjahr 2020 durchzuführen.
By completing the acquisition of specialty chemicals distributor Axieo, DKSH continues to drive market consolidation and assumes a leading role in the Australian and New Zealand markets.
By closing the acquisition of the largest field marketing provider Crossmark in Australia and New Zealand, DKSH once again acquires a target in a growing business segment and adds value for its clients and customers.
DKSH and Morinaga, the owner of the iconic brands Hi-Chew and Dars Chocolate, have decided to expand their success story to another key market in Southeast Asia, Vietnam.
DKSH erweitert die seit über 13 Jahren erfolgreiche Partnerschaft mit Right To Play. Gemeinsam mit der Liverpool FC Foundation investieren die drei Partner in das Wohlergehen von Kindern, Jugendlichen und Gemeinden in Thailand.
DKSH has expanded its 13-year long successful partnership with Right To Play. Together with Liverpool FC Foundation, the three partners are investing in the well-being of children, youth and communities in Thailand.
DKSH grew net sales and EBITGood progress with restructuring yielded higher result for Business Unit Consumer GoodsAcquisition strategy pursued with four value-creating transactionsProposal to increase ordinary dividend to CHF 1.90 per share (+2.7%)Confident for outlook 2020
The agreement to acquire specialty chemicals distributor Axieo is a continuation of DKSH's acquisition strategy, allowing the company to expand its coverage in Asia Pacific and to become a market leader in Australia and New Zealand.
Mit der Vereinbarung zur Übernahme des Spezialchemie-Distributeurs Axieo setzt DKSH die Akquisitionsstrategie erfolgreich fort, erweitert die Abdeckung in Asien Pazifik und wird zu einem führenden Anbieter in Australien und Neuseeland.
DKSH Vietnam launched “Step up!”, a dynamic incentive campaign, that encourages its employees to increase their physical activity and to care for the less fortunate. The initiative's goal is to challenge all participants to take at least 4,000 steps a day to establish and maintain a healthier lifestyle, while contributing to the local community.
DKSH has signed an agreement to acquire the field marketing provider Crossmark. With this transaction, DKSH pursues its acquisition strategy – which has been accelerated since 2017 – and strengthens the service portfolio of the Business Unit Consumer Goods in Asia Pacific.
DKSH hat eine Vereinbarung zur Übernahme des Field Marketing-Anbieters Crossmark unterzeichnet. Damit setzt DKSH die seit 2017 intensivierte Akquisitionsstrategie fort und verstärkt das Dienstleistungsportfolio der Geschäftseinheit Konsumgüter in Asien Pazifik.
Durch die Partnerschaft mit Plant-for-the-Planet stellt DKSH die Standorte der Gründungsmärkte klimaneutral und kompensiert zudem die Flugreisen. DKSH übernimmt damit die Verantwortung für CO2-Emissionen aus den eigenen Geschäftsaktivitäten und verstärkt das Engagement im Bereich Nachhaltigkeit.
Together with Plant-for-the-Planet, DKSH sets its founding markets climate-neutral and additionally compensates emissions from air travel. In doing this, DKSH takes responsibility for CO2-emissions from business activities and strengthens its commitment in the area of Sustainability.
DKSH, the leading Market Expansion Services provider with a focus on Asia, has been appointed by Tipco F&B Company Limited to market and distribute their products across Thailand. The partnership includes the company's ready-to-drink Tipco fruit juices, vegetable juice products and Aura natural mineral water.
Net sales of CHF 5.6 billion matched the previous year's level (underlying growth: 3.1% organic plus 1.2% M&A). The operating profit (EBIT) was below last year due to the exit of the Healthcare business in China (CHF 17.1 million) and restructuring costs in Consumer Goods (CHF 13.3 million). Excluding these effects, the adjusted EBIT grew 1.3% to CHF 124.0 million. In line with the acquisition strategy, DKSH has already acquired four value-accretive businesses.
Der Nettoumsatz lag mit CHF 5.6 Milliarden auf Vorjahresniveau (unterliegendes Wachstum: 3.1% organisch plus 1.2% M&A). Durch den Wegfall des Healthcare-Geschäfts in China (CHF 17.1 Millionen) und Restrukturierungskosten in Konsumgüter (CHF 13.3 Millionen) lag der Betriebsgewinn (EBIT) unter Vorjahr. Bereinigt um diese Effekte wuchs der adjustierte EBIT um 1.3% auf CHF 124.0 Millionen. In Einklang mit der Akquisitionsstrategie tätigte DKSH bereits vier wertsteigernde Übernahmen.
Zum zweiten Mal in Folge veröffentlicht DKSH den GRI-Bericht über ökonomische, ökologische und soziale Aktivitäten. Damit unterstreicht DKSH die Anstrengungen zur kontinuierlichen Verbesserung im Nachhaltigkeitsbereich. Zudem zeigt der Bericht erstmals den Beitrag zu den UNO-Zielen für nachhaltige Entwicklung auf.
DKSH publishes the second report on its environmental, social and governance performance based on the Global Reporting Initiative (GRI). The report demonstrates DKSH's commitment to continually stepping up sustainability efforts. The company also includes its contribution to the United Nations Sustainable Development Goals for the first time.
DKSH has signed an agreement to acquire the distributor CTD in Australia. With this move, DKSH strengthens Business Unit Consumer Goods and expands its presence in Asia Pacific. The transaction follows DKSH's acquisition strategy of buying accretive and complementary businesses.
DKSH hat eine Vereinbarung zur Übernahme des Distributors CTD in Australien unterzeichnet. Damit stärkt DKSH die Geschäftseinheit Konsumgüter und erweitert die Präsenz in Asien-Pazifik. Die Transaktion steht in Einklang mit der Akquisitionsstrategie von DKSH, in der wertsteigernde und komplementäre Geschäfte erworben werden.
By acquiring specialty chemicals distributor Dols International, DKSH Business Unit Performance Materials expands its presence in Benelux.
Mit der Akquisition des Spezialchemie-Distributeurs Dols International baut die Business Unit Performance Materials von DKSH ihre Präsenz in den Benelux-Staaten aus.
DKSH has been rewarded for its commitment to Sustainability with the internationally recognized EcoVadis silver rating. With an overall score of 50 points, DKSH ranks among the top 14% of companies in the industry. As a Swiss company with a legacy of over 150 years in Asia, Sustainability is an integral part of DKSH's business model.
DKSH has completed the acquisition of the consumer goods distribution business of Auric Pacific in Singapore and Malaysia. The transaction is the largest acquisition since the merger of DKSH in 2002 and underlines DKSH's strategy to acquire complementary and high-margin businesses.
DKSH hat die Übernahme des Konsumgütergeschäfts von Auric Pacific in Singapur und Malaysia erfolgreich abgeschlossen. Die Transaktion ist die grösste seit dem Zusammenschluss von DKSH im Jahr 2002 und reiht sich ein in die Strategie von DKSH zum Erwerb von margenstarken und komplementären Geschäftsfeldern.
Marco Gadola, Dr. Wolfgang Baier and Jack Clemons elected as new Board membersAdrian T. Keller elected as Chairman for a one-year term of officeShareholders authorized dividend increase of 12.1% to CHF 1.85 per shareAll other motions approved with clear majority
Marco Gadola, Dr. Wolfgang Baier und Jack Clemons als neue Mitglieder gewähltAdrian T. Keller als Verwaltungsratspräsident für das Amtsjahr 2019 bestätigtDividendenerhöhung um 12.1% auf CHF 1.85 pro Aktie angenommenGeneralversammlung stimmt allen übrigen Anträgen mit grosser Mehrheit zu
DKSH has signed an agreement to acquire technology distributor SPC. With this move, DKSH's Business Unit Technology becomes the largest player for scientific instrumentation in Thailand. DKSH continues to pursue its acquisition strategy for complementary high-margin businesses, which has been enhanced since 2017.
DKSH hat eine Vereinbarung zur Übernahme des Technologie-Distributors SPC unterzeichnet. Damit wird die Geschäftseinheit Technologie zum bedeutensten Anbieter für analytische Instrumente in Thailand. Mit der Transaktion setzt DKSH die seit 2017 intensivierte Akquisitionsstrategie fort, in der margenstarke und komplementäre Geschäfte erworben werden.
Marco Gadola, Dr. Wolfgang Baier und Jack Clemons zur Wahl vorgeschlagenAn der Generalversammlung 2020 wird sich Marco Gadola als Verwaltungsratspräsident zur Verfügung stellenAdrian T. Keller als Verwaltungsratspräsident für das Amtsjahr 2019 vorgeschlagenSechs bisherige Verwaltungsratsmitglieder stehen zur Wiederwahl
Marco Gadola, Dr. Wolfgang Baier and Jack Clemons are proposed for electionAt the Ordinary General Meeting 2020, Marco Gadola will stand for election as ChairmanAdrian T. Keller is proposed as Chairman for one term of office in 2019Six existing members of the Board stand for re-election
Net sales increased by 3.1% to CHF 11.3 billionProfit after tax grew by 22.0% to CHF 260.3 million (incl. sale of Healthcare business in China)EBIT of CHF 263.6 million included one-time effects of CHF 20.7 millionRestructuring initiated in Business Unit Consumer GoodsProposal to increase ordinary dividend to CHF 1.85 per share (+12.1%)Outlook 2019: increased operating result expectedChanges to the Board of Directors
Nettoumsatz steigt um 3.1% auf CHF 11.3 MilliardenGewinn nach Steuern wächst mit 22.0% auf CHF 260.3 Millionen (inkl. Verkauf Healthcare China)EBIT von CHF 263.6 Millionen durch Einmaleffekte von CHF 20.7 Millionen belastetRestrukturierung im Bereich Konsumgüter eingeleitetVorschlag zur Erhöhung der ordentlichen Dividende auf CHF 1.85 pro Aktie (+12.1%)Ausblick 2019: Steigerung des operativen Gewinns erwartetVeränderungen im Verwaltungsrat
DKSH hat eine Vereinbarung zur Übernahme des Distributionsgeschäfts für Konsumgüter von Auric Pacific unterzeichnet. Damit erweitert DKSH das margenstarke Food-Service-Geschäft und baut seine Präsenz im Bereich Konsumgüter in Asien aus.
DKSH has signed an agreement to acquire the consumer goods distribution business of Auric Pacific in Singapore and Malaysia. With this move, DKSH increases its exposure to the high-margin food service business and expands its presence in the consumer goods industry in Asia.
Martina Ludescher, Chief Commercial Officer, Leiterin der Geschäftseinheit Konsumgüter und Mitglied der Konzernleitung, verlässt DKSH, um sich neuen Herausforderungen ausserhalb des Unternehmens zu stellen.
DKSH announced today that Martina Ludescher, Chief Commercial Officer, Head Business Unit Consumer Goods and Member of the Executive Board, will leave the company to pursue other challenges outside of DKSH.
Mit der Veräusserung des Komponentenherstellers Queloz an die Cendres+Métaux Group setzt DKSH die erfolgreiche Restrukturierung des Luxusgütergeschäfts fort. DKSH gewährleistet somit, dass Queloz weiter in Schweizer Hand bleibt.
With the sale of the watch case manufacturer Queloz to the Cendres+ Métaux Group, DKSH continues the successful restructuring of its luxury goods business. Queloz remains in Swiss hands.
DKSH has successfully completed the sale of its healthcare business in China to Warburg Pincus. The transaction emphasizes DKSH's increased strategic focus. With a purchase price of around CHF 100 million, DKSH has now realized the value created over the years.
DKSH hat den Verkauf des Healthcare-Geschäfts in China an Warburg Pincus erfolgreich abgeschlossen. Mit der Transaktion unterstreicht DKSH den verstärkten strategischen Fokus des Unternehmens und realisiert – mit einem Verkaufspreis in der Höhe von ca. CHF 100 Millionen –den über die Jahre erschaffenen Wert.
Mit der Modernisierung des Distributionszentrums von Wicaksana in Jakarta erhält DKSH die IPAK-Lizenz des indonesischen Gesundheitsministeriums zur Vermarktung von Medizintechnik. DKSH hatte PT Wicaksana vor einem Jahr übernommen und damit den Markteintritt für die Geschäftseinheiten Healthcare und Konsumgüter ermöglicht.
Along with a recent upgrade of Wicaksana's distribution center in Jakarta, DKSH has received the IPAK license for medical device distribution from the Indonesian Ministry of Health. DKSH's acquisition of Wicaksana one year ago, is paving the way for the market entry of its Business Units Consumer Goods and Healthcare.
DKSH und das börsennotierte australische Rohstoffunternehmen TNG haben eine Grundsatzvereinbarung zur exklusiven und globalen Vermarktung von TNGs Titandioxid (TiO2) abgeschlossen. TiO2 ist das weltweit am meisten eingesetzte Weisspigment.
DKSH and Australian stock listed resources company TNG have signed a term sheet encompassing the full distribution on a global and exclusive basis for TNG's titanium dioxide (TiO2) production. TiO2 is the most used white pigment worldwide.
Dr. Jörg Wolle übergibt auf Generalversammlung 2019 Präsidium des VerwaltungsratesWolle: „Weichen für eine erfolgreiche Zukunft gestellt“
Dr. Joerg Wolle to hand over the Chairmanship of the Board of Directors at 2019 Annual General MeetingWolle: "On course for a successful future"
DKSH präsentiert den ersten ausführlichen Bericht über die ökonomischen, ökologischen und sozialen Aktivitäten gemäss den international anerkannten Richtlinien der Global Reporting Initiative (GRI). Als Schweizer Unternehmen mit einer über 150-jährigen Präsenz in Asien ist nachhaltiges Handeln ein integraler Bestandteil des DKSH-Geschäftsmodells.
DKSH publishes the first report on its economic, environmental and social activities based on the internationally recognized Global Reporting Initiative guidelines (GRI). As a Swiss company with more than 150 years of tradition in Asia, good corporate citizenship is an integral part of DKSH's business model.
DKSH ensures continuity in leadership by appointing Daniel Culverhouse as Head Supply Chain Management, effective October 1, 2018.
Nettoumsatz steigt um 7.4% auf CHF 5.7 MilliardenBetriebsgewinn (EBIT) mit 0.5% auf und Gewinn nach Steuern mit 4.5% über VorjahrLeistungssteigerung der Geschäftseinheiten Healthcare, Spezialrohstoffe und TechnologieVerstärkter strategischer Fokus: Verkauf des Healthcare-Geschäfts in China und Akquisition in NeuseelandDKSH erwartet für 2018 weiteres Umsatzwachstum und ein operatives Ergebnis im Rahmen des Vorjahres
Net sales increased by 7.4% to CHF 5.7 billionOperating profit (EBIT) grew by 0.5% and profit after tax by 4.5% above last year's levelsImproved performance in Business Units Healthcare, Performance Materials and TechnologyIncreased strategic focus: transfer of healthcare business in China and acquisition in New ZealandFor 2018, DKSH expects further net sales growth and an operating result around last year's level
For many years, DKSH has pursued a niche strategy in the Chinese healthcare market. DKSH now announced an agreement to transfer this business to Warburg Pincus. The transaction emphasizes DKSH's increased strategic focus, realizing the value created over the years. DKSH continues to be present with its Consumer Goods, Performance Materials and Technology businesses in China.
Im Bereich Healthcare hat DKSH seit vielen Jahren eine Nischenstrategie in China verfolgt. DKSH kündigt nun den Transfer dieses Geschäfts an Warburg Pincus an. Mit der Transaktion unterstreicht DKSH den verstärkten strategischen Fokus und realisiert den über die Jahre erschaffenen Wert. DKSH bleibt in China mit den Geschäftseinheiten Konsumgüter, Spezialrohstoffe und Technologie präsent.
DKSH gibt die Übernahme des Getränkegeschäfts von Davies Foods in Neuseeland bekannt. Damit positioniert sich DKSH für weiteres Wachstum in Neuseeland.
DKSH announces the acquisition of Davies Foods' beverage business in New Zealand. With the takeover, DKSH positions itself for additional growth in New Zealand.
DKSH announced today that Christopher Pollard, Head of Supply Chain Management, has decided to leave the company to pursue other challenges outside of DKSH.
Christopher Pollard, Head Supply Chain Management, verlässt DKSH, um sich neuen Herausforderungen ausserhalb des Unternehmens zu widmen.
Approval of the Financial Statements and Group Consolidated Financial Statements for the financial year 2017Shareholders authorized the distribution of an ordinary dividend of CHF 1.65 per shareAll members of the Board of Directors and Senior Executive Team were dischargedApproval of the compensation of the Board of Directors and Senior Executive TeamElection of Prof. Dr. Annette G. Köhler and Eunice Zehnder-Lai as new members of the Board of DirectorsShareholders voted in favor of all Board members who stood for re-election, re-elected the Chairman and elected four members to the Nomination and Compensation CommitteeRe-election of Statutory Auditors and Independent Proxy
Net sales grow by 4.8% in 2017 to CHF 11.0 billionOperating profit (EBIT) increases to CHF 297.0 millionProfit after tax of CHF 213.3 million slightly above last year's levelSuccessful market entry in Indonesia and expansion of digital businessProposal to increase ordinary dividend by 10.0% to CHF 1.65 per shareIncreased net sales and profit growth rate expectedTwo new members of the Board of Directors proposed for election
Nettoumsatz wächst in 2017 um 4.8% auf CHF 11.0 MilliardenBetriebsgewinn (EBIT) mit CHF 297.0 Millionen über 2016Gewinn nach Steuern mit CHF 213.3 Millionen leicht über VorjahresniveauErfolgreicher Markteintritt in Indonesien und Ausbau der DigitalisierungVorschlag zur Erhöhung der ordentlichen Dividende um 10.0% auf CHF 1.65 pro AktieErhöhtes Umsatz- und Gewinnwachstum erwartetZwei neue Mitglieder zur Wahl in Verwaltungsrat vorgeschlagen
DKSH-Chief Information Officer Michael Hutab wird in die erweiterte Geschäftsleitung berufen. Mit diesem Schritt unterstreicht DKSH die Wichtigkeit der Digitalisierung und den hohen Stellenwert einer integrierten und zentralisierten IT-Plattform in der Gruppe.
Michael Hutab, Chief Information Officer at DKSH, will join the Group Management team. With this move, DKSH underlines the importance of digitization and the significance of an integrated and centralized IT platform within the Group.
DKSH participates in another funding round at aCommerce, a leading e-commerce service provider in South East Asia. KKR subsidiary Emerald Media is also among the investors. The investment complements DKSH's position as a leading pan-Asian e-commerce servicer provider distributing more than 400 brands online.
Acquisition of 60 percent of shares in PT Wicaksana provides the basis for DKSH's market entry in Indonesia for Business Units Consumer Goods and HealthcareClear commitment for growth in South East Asia's most populous country
Net sales grow by 3.8% to CHF 5.3 billion (+3.0% at CER)Operating profit (EBIT) increases by 2.3% to CHF 138.8 millionProfit after tax slightly above last year's levelHigher Free Cash Flow of CHF 56.7 millionDKSH achieves strategic market entry in Indonesia for Consumer Goods and HealthcareFurther net sales and profit growth expected
Nettoumsatz steigt um 3.8% auf CHF 5.3 Milliarden (+3.0% zu k.W.)Betriebsgewinn (EBIT) wächst um 2.3% auf CHF 138.8 MillionenGewinn nach Steuern leicht über VorjahresniveauHöherer Free Cashflow von CHF 56.7 MillionenDKSH gelingt strategischer Markteintritt in Indonesien für Konsumgüter und HealthcareWeiteres Umsatz- und Gewinnwachstum erwartet
DKSH, der führende Dienstleister für Marktexpansion mit Schwerpunkt Asien, gründet eine Partnerschaft mit der Wicaksana Gruppe und beabsichtigt die Mehrheit der Aktien an PT Wicaksana, einem etablierten Distributor von Konsumgütern und Pharma-Produkten mit Sitz in Jakarta, Indonesien, zu übernehmen. Mit der Partnerschaft und Akquisition baut DKSH seine Marktpräsenz im bevölkerungsreichsten Land Südostasiens weiter aus.
DKSH, the leading Market Expansion Services provider with a focus on Asia, creates a partnership with the Wicaksana Group and intends to acquire the majority of shares of PT Wicaksana, an established distributor of consumer goods and pharmaceutical products based in Jakarta, Indonesia. Through the partnership and acquisition, DKSH further expands its position in the most populous country in South East Asia.
Die Halbjahresergebnisse 2017 der DKSH Holding AG (SIX: DKSH) werden am Donnerstag, den 13. Juli 2017 veröffentlicht.
DKSH Holding Ltd. (SIX: DKSH) reports its half-year results 2017 on Thursday, July 13, 2017
DKSH has been rated as one of the 50 most trustworthy companies in Western Europe by US business magazine Forbes. Among the 1,400 European-based companies considered, six Swiss corporations including DKSH made it to the top ranks.
DKSH wurde vom US-Wirtschaftsmagazin Forbes als eines der 50 vertrauenswürdigsten Unternehmen in Westeuropa ausgezeichnet. Unter den 1,400 betrachteten europäischen Firmen haben es neben DKSH fünf weitere Schweizer Unternehmen ins Top-Ranking geschafft.
DKSH, the leading Market Expansion Services provider with a focus on Asia, today announces that Andrew Frye, since 2011 with DKSH and since 2015 Head of Business Unit Healthcare, has decided to take on a senior position at a healthcare client company.
DKSH, der führende Dienstleister für Marktexpansion mit Schwerpunkt Asien, gibt heute bekannt, dass Andrew Frye, seit 2011 bei DKSH und seit 2015 Head Business Unit Healthcare, sich entschieden hat, eine führende Position bei einem Pharmahersteller anzutreten. DKSH dankt Andrew Frye für seine wertvolle Arbeit und wünscht Ihm alles Gute für die Zukunft.
DKSH today announced the acquisition of Innovative Marketing Actions (IMA) in Vietnam. With the transaction, DKSH becomes the largest field marketing provider in the country and is well positioned for further growth in Vietnam.
Jahresrechnung und Konzernrechnung für das Geschäftsjahr 2016 genehmigtAktionäre stimmen Ausschüttung einer ordentlichen Dividende von CHF 1.50 pro Aktie und einer Sonderdividende von CHF 3.00 pro Aktie zuAlle Mitglieder des Verwaltungsrats und der Geschäftsleitung entlastetVergütung der Mitglieder des Verwaltungsrats und der Geschäftsleitung genehmigtWiederwahl aller Mitglieder des Verwaltungsrats sowie Wahl des Verwaltungsratspräsidenten und der Mitglieder des Nominierungs- und VergütungsausschussesWiederwahl der Revisionsstelle und des unabhängigen Stimmrechtsvertreters
Financial Statements and Group Consolidated Financial Statements for the financial year 2016 approvedShareholders resolve distribution of an ordinary dividend of CHF 1.50 per share and a special dividend of CHF 3.00 per shareAll members of the Board of Directors and of the Executive Board dischargedApproval of the compensation of the members of the Board of Directors and Executive BoardRe-election of all Board members as well as election of the Chairman and members of the Nomination and Compensation CommitteeRe-election of Statutory Auditors and Independent Proxy
Net sales grow in 2016 by 4.5% to CHF 10.5 billionOperating profit (EBIT) increases over-proportionally by 8.4% to CHF 293.0 millionProfit after tax of CHF 213.0 million significantly above last yearProposal to increase ordinary dividend by 15.4% to CHF 1.50 per shareAdditional special dividend of CHF 3.00 per share proposedFurther net sales and profit growth expected
Nettoumsatz wächst in 2016 um 4.5% auf CHF 10.5 MilliardenBetriebsgewinn (EBIT) steigt überproportional um 8.4% auf CHF 293.0 MillionenGewinn nach Steuern mit CHF 213.0 Millionen deutlich über VorjahrVorschlag zur Erhöhung der ordentlichen Dividende um 15.4% auf CHF 1.50 pro AktieZusätzliche Sonderdividende von CHF 3.00 pro Aktie vorgeschlagenWeiteres Umsatz- und Gewinnwachstum erwartet
DKSH, the leading Market Expansion Services provider with a focus on Asia, today announced the acquisition of Europ Continents Cambodia, a major provider of medical devices, in vitro diagnostic and laboratory products in Cambodia. As one of the fastest-growing companies in Cambodia, DKSH further strengthens its leading position in the healthcare sector with this transaction and drives forward the consolidation of the Market Expansion Services industry in Asia.
The continued positive growth dynamics in the Asian markets offer promising development opportunities for companies. With an average annual growth rate of 6.5% over the next five years, the future outlook of Market Expansion Services in Asia remains prosperous as shown by the new study from Roland Berger.
DKSH Holding Ltd. (SIX: DKSH) reports its full-year results 2016 on Monday, February 6, 2017
The food supplements manufactured by Scotch Industrial Co. Ltd are very popular among the Thai population – Scotch Bird's Nest and Scotch's Essence of Chicken are synonymous for a healthy lifestyle. DKSH now assumes marketing and sales of Scotch's products in Thailand and paves the way for further expansion in other Asian markets. Dr. Joerg Wolle, President & CEO of DKSH: “A strategic success for DKSH in one of the most relevant markets in Asia.”
DKSH, the leading Market Expansion Services provider with a focus on Asia, today announced – coherent with its long-term planning and as communicated well in advance – the next step of transition among its top management.
DKSH, das führende Unternehmen im Bereich Marktexpansionsdienstleistungen mit Schwerpunkt Asien, gibt heute den nächsten Schritt beim langfristig geplanten und frühzeitig kommunizierten Wechsel an der Unternehmensspitze bekannt.
DKSH, Zurich, has been appointed by the consumer goods multinational The Procter & Gamble Company, Cincinnati/USA (P&G) to sell and distribute P&G's brands in Hong Kong. DKSH as the leading Market Expansion Services provider with a focus on Asia started these sales and distribution activities for P&G with effect from October 1, 2016.
DKSH today announced the acquisition of a majority stake in Shanghai Sweets International (eSweets), a fast-growing Chinese online distributor of premium consumer goods, based in Shanghai. DKSH creates value for the company's clients and customers, thereby directly contributing to DKSH's growth.
DKSH veräussert ihre Mehrheitsbeteiligung an der Uhrenmanufaktur Glycine Watch S.A. an die Invicta Watch Group, einem US-amerikanischen Uhrenhersteller.
DKSH sells its majority stake in Glycine Watch S.A. to the Invicta Watch Group, a US watch manufacturer.
Stefan P. Butz designierter neuer CEODr. Jörg Wolle soll Präsident des Verwaltungsrates werden
Stefan P. Butz designated new CEODr. Joerg Wolle to become Chairman of the Board of Directors
Net sales grow by 2.3% to CHF 5.1 billionDKSH gains further market sharesOperating profit (EBIT) of CHF 135.7 million impacted by one-time contract adjustments in Business Unit Healthcare. Excluding adjustments, EBIT exceeds last year's levelIncreasing demand for performance materials for the industrial development and expansion leads to substantially higher profitability in this Business UnitMeasures in the luxury goods business start to take effectPositive trend intact: DKSH continues to expect net sales and earnings growth for full-year
Financial Statements and Group Consolidated Financial Statements for the financial year 2015 approvedShareholders resolve distribution of an ordinary dividend of CHF 1.30 per shareAll members of the Board of Directors and of the Executive Board dischargedApproval of the compensation of the members of the Board of Directors and the Executive BoardRe-election of all Board members including Chairman, Nomination and Compensation Committee as well as Statutory Auditors and Independent Proxy
Jahresrechnung und Konzernrechnung für das Geschäftsjahr 2015 genehmigtAktionäre stimmen Ausschüttung einer ordentlichen Dividende von CHF 1.30 pro Aktie zuAlle Mitglieder des Verwaltungsrats und der Geschäftsleitung entlastetVergütung der Mitglieder des Verwaltungsrats und der Geschäftsleitung genehmigtWiederwahl aller Mitglieder des Verwaltungsrats inklusive Präsident, des Nominierungs- und Vergütungsausschusses sowie der Revisionsstelle und des unabhängigen Stimmrechtsvertreters
Dr. Joerg Wolle, President & CEO, will change to the Chair of the Board of Directors of DKSH in 2017. This long-planned decision sends an important signal for continuity, foresight and confidence in further growth of the DKSH Group.
Dr. Jörg Wolle, CEO und Delegierter des Verwaltungsrats, wechselt 2017 an die Spitze des Verwaltungsrats. Diese langfristige Weichenstellung setzt ein wichtiges Signal für Kontinuität, Voraussicht und den Anspruch auf weiteres Wachstum der DKSH Gruppe.
Net sales increase by 2.4% to CHF 10.1 billionProfit after tax grows by 2.1% to CHF 199.6 million in a challenging market environmentEarnings per share increase by 5.4%Proposal to increase ordinary dividend by 13.0% to CHF 1.30 per shareResilience of business model reconfirmed in spite of difficult conditions ‒ restructuring of luxury goods business in H2 2015 initiatedDKSH sees further potential for market share gains and growth
Nettoumsatz steigt um 2.4% auf CHF 10.1 MilliardenIn anspruchsvollem Marktumfeld wächst der Gewinn nach Steuern um 2.1% auf CHF 199.6 MillionenGewinn pro Aktie steigt um 5.4%Vorschlag zur Erhöhung der ordentlichen Dividende um 13.0% auf CHF 1.30 pro AktieRobustheit des Geschäftsmodells trotz widriger Bedingungen wiederum unter Beweis gestellt ‒ Restrukturierung des Luxusgütergeschäfts in H2 2015 eingeleitetDKSH sieht weiteres Potential für Marktanteilsgewinne und Wachstum
DKSH schliesst eine strategische Partnerschaft mit aCommerce, dem führenden Anbieter für E-Commerce-Dienstleistungen in Südostasien. DKSH verstärkt ihren bereits gut etablierten Omni-ChannelAnsatz – bei dem Herstellerprodukte sowohl über die traditionellen Vertriebskanäle als auch die schnell wachsenden Onlinekanäle vertrieben werden – nochmals mit der Akquisition eines strategischen Aktienanteils von 20% an aCommerce.
DKSH today announced that it has formed a strategic partnership with aCommerce, the leading e-commerce solutions provider in South East Asia. Acquiring a strategic 20% equity stake in aCommerce proves DKSH's commitment to further strengthen its omni-channel approach, thereby selling client products through both the well-established offline trade channels and the fast growing online channels.
• Terroranschläge in Thailand haben begrenzten Einfluss auf DKSH• Für 2015 erwartet DKSH Umsatz und Gewinn im Rahmen des Vorjahres• Intakte Wachstumstreiber in Asien fördern nachhaltiges Wachstum• Fortsetzung der bewährten progressiven Dividendenpolitik
• Terror attacks in Thailand have limited impact on DKSH• DKSH expects net sales and profit for 2015 similar to last year's levels• Intact growth drivers in Asia support sustainable growth• Proven progressive dividend policy will continue
Anschlagserie in Thailand sollte gezielt den Tourismus und damit die wirtschaftliche Entwicklung schädigenLangfristige Wachstumstreiber in ASEAN weiterhin intaktProgressive Dividendenpolitik der DKSH
Series of attacks in Thailand targeted to damage tourism and therewith economic developmentLong-term growth drivers in ASEAN remain intactProgressive dividend policy of DKSH
Net sales grow by 7.6% to CHF 5.0 billionOperating profit (EBIT) increases by 6.2% to CHF 139.5 millionSolid Free Cash Flow of CHF 86.5 millionProfit after tax grows double-digit by 15.5% to CHF 105.9 millionTransfer of two own pharma brands and restructuring of luxury goods businessNew allocation of responsibilities within the Executive BoardDKSH maintains targets
Nettoumsatz steigt um 7.6% auf CHF 5.0 MilliardenBetriebsgewinn (EBIT) wächst um 6.2% auf CHF 139.5 MillionenSolider Free Cashflow von CHF 86.5 MillionenGewinn nach Steuern wächst zweistellig um 15.5% auf CHF 105.9 MillionenTransfer zweier Pharma-Eigenmarken und Restrukturierung des LuxusgütergeschäftsNeue Ressortverteilung in der KonzernleitungDKSH hält an Zielen fest
DKSH, the leading Market Expansion Services provider, today announced the acquisition of Andreas Jennow, a top-ranking specialty chemicals distributor in Northern Europe. With this move, DKSH Business Unit Performance Materials strengthens its geographic coverage in Europe, complements its market leadership in Asia and drives forward the consolidation of the chemical distribution industry.
DKSH, the leading Market Expansion Services provider with a focus on Asia, today announced the geographic expansion of its joint venture DKSH Smollan Field Marketing to Myanmar and Singapore.
DKSH, der führende Dienstleister für Marktexpansion, hat heute die Übernahme von Andreas Jennow, einem etablierten Spezialchemie-Distributor in Nordeuropa, bekannt gegeben. Mit diesem Schritt erweitert die DKSH-Geschäftseinheit Spezialrohstoffe ihre geographische Abdeckung in Europa, ergänzt die Marktführerschaft in Asien und treibt die Konsolidierung der Chemiedistributions-branche weiter voran.
DKSH, the leading Market Expansion Services provider with a focus on Asia, will provide e-fulfillment services to Yahoo's e-commerce business in Taiwan. The recent agreement showcases DKSH's ability to provide a broad range of services to both offline as well as online trade channels in Asia.
Jahresbericht, Jahresrechnung und Konzernrechnung für das Geschäftsjahr 2014 genehmigtAktionäre stimmen ordentlicher Dividende von CHF 1.15 pro Aktie zuAlle Mitglieder des Verwaltungsrats und der Konzernleitung entlastetZustimmung zur Revision der Statuten der DKSH zur Implementierung der Regelungen im Zusammenhang mit der Minder-VerordnungVergütung des Verwaltungsrats und der Konzernleitung genehmigtWiederwahl aller Mitglieder des Verwaltungsrats inklusive Präsident, des Nominierungs- und Vergütungsausschusses, der Revisionsstelle und des unabhängigen Stimmrechtsvertreters
Annual Report, Annual Financial Statements and Consolidated Financial Statements for the financial year 2014 approvedShareholders resolve ordinary dividend of CHF 1.15 per shareAll Board of Directors and Executive Board members dischargedRevision of DKSH's Articles of Association for implementation of the rules relating to the Minder Ordinance acceptedApproval of Board of Directors and Executive Board compensationRe-election of all Board members including Chairman, Nomination and Compensation Committee, Statutory Auditors and Independent Proxy
DKSH, der führende Dienstleister für Marktexpansion mit Fokus auf Asien, hat heute den Transfer der beiden Pharma-Eigenmarken Combizym und Hirudoid an CMS, einen etablierten chinesischen Pharmadistributor, bekannt gegeben. Die gezielte Veräusserung optimiert das Eigenmarkenportfolio von DKSH im Bereich Pharma in China und unterstreicht die strategische Ausrichtung als Nischen-spezialist im chinesischen Markt.
DKSH, the leading Market Expansion Services provider with a focus on Asia, today announced the transfer of two own pharmaceutical brands Combizym and Hirudoid to CMS, a leading Chinese pharmaceutical services provider. This selective divestment further optimizes DKSH's healthcare own brands portfolio in mainland China and emphasizes DKSH's strategy as a niche specialist in the Chinese market.
Nettoumsatz steigt um 7.1% zu konstanten Wechselkursen auf CHF 10.2 Milliarden und führt zu Marktanteilsgewinnen in KernmärktenTrotz widriger als erwartetem Marktumfeld in Thailand, China, Hong Kong und Japan liegt der Betriebsgewinn mit CHF 284.1 Millionen zu konstanten Wechselkursen über dem VorjahreswertStabiler Ertrag und Umsatzwachstum unterstreichen die Robustheit des DKSH-Geschäftsmodells im anspruchsvollsten Geschäftsjahr 2014Verwaltungsrat erhöht langfristige Dividenden-Ausschüttungsquote auf 30–50% des Gewinns nach SteuernAngesichts der Zuversicht für die kommenden Geschäftsjahre wird eine Steigerung der ordentlichen Dividende 2014 um 21% (+CHF 0.20) auf CHF 1.15 pro Aktie vorgeschlagenFür 2015 weiterhin dynamisches Nettoumsatzwachstum und zweistelliges EBIT-Wachstum zu konstanten Wechselkursen erwartetDKSH bestätigt Ausblick 2016
Net sales grow by 7.1% to CHF 10.2 billion at constant exchange rates resulting in market share gains in core marketsDespite the more challenging than expected business environment in Thailand, China, Hong Kong and Japan, operating profit of CHF 284.1 million at constant exchange rates exceeds last year's levelStable income and net sales growth underline resilience of DKSH's busi-ness model in highly challenging year 2014Board of Directors has decided to increase long-term dividend payout ratio to 30–50% of profit after taxGiven the favorable outlook for the coming years, proposal to increase the ordinary dividend 2014 by 21% (+CHF 0.20) to CHF 1.15 per shareContinued dynamic net sales growth and double-digit EBIT growth ex-pected for 2015 at constant exchange ratesDKSH confirms 2016 outlook
DKSH, the leading Market Expansion Services provider with a focus on Asia, operates in an attractive market with a projected growth of 7.4% per year up to 2019, as confirmed by the most recent market study conducted by Roland Berger Strategy Consultants.
DKSH, the leading Market Expansion Services provider with a focus on Asia, has achieved top 3 ranking in the category “Best new listed company 2014” at the European Small and Mid-Cap Awards. These annual Awards recognize the best European small and mid-sized companies who gained access to capital markets through initial public offerings.
Net sales growth of 6.7% at constant exchange ratesDepreciation of Asian currencies impact results negatively by 9.6%Operating profit in a challenging market environment, at constant exchange rates, slightly above last year's levelImpact from political unrest in Thailand more profound than expected at the beginning of the yearDKSH confirms outlook
Nettoumsatz wächst um 6.7% zu konstanten WechselkursenWechselkursverwerfungen beeinflussen Resultate negativ mit 9.6%Betriebsgewinn in anspruchsvollem Marktumfeld zu konstanten Wechselkursen leicht über VorjahresniveauAuswirkungen politischer Unruhen in Thailand tiefgreifender als Anfang Jahr erwartetDKSH bestätigt Ausblick
DKSH, der führende Dienstleister für Marktexpansion, hat heute die Übernahme von Zeus Química, einem etablierten SpezialchemieDistributor in Spanien und Portugal, bekannt gegeben. DKSH's Geschäftseinheit Spezialrohstoffe stärkt damit erheblich die Präsenz in Europa und ergänzt ihre Marktführerschaft in Asien. Mit diesem Schritt treibt DKSH die kontinuierliche Konsolidierung der Chemiedistributionsbranche weiter voran.
DKSH, the leading Market Expansion Services provider, today announced the acquisition of Zeus Química, a top-ranking specialty chemicals distributor in Spain and Portugal. DKSH Business Unit Performance Materials considerably strengthens its market position in Europe, thereby complementing its market leadership in Asia. With this move, DKSH is driving forward the ongoing consolidation of the chemical distribution industry.
Jahresbericht, Jahresrechnung und Konzernrechnung für das Geschäftsjahr 2013 genehmigtZustimmung zur ordentlichen Dividende und zur Sonderdividende in Gesamthöhe von CHF 1.10 pro AktieEntlastung für alle Mitglieder des Verwaltungsrats und der Konzernleitung erteiltWiederwahl des gesamten Verwaltungsrats inklusive Präsident sowie Zuwahl von David KamenetzkyErstmalige Wahl der Mitglieder des Ernennungs- und Vergütungsausschusses und des unabhängigen Stimmrechtsvertreters durch die Generalversammlung
Annual Report, annual financial statements and consolidated financial statements for the financial year 2013 approved Ordinary and extraordinary dividend totaling CHF 1.10 per share resolved Discharge of all members of the Board of Directors and Executive Board Reelection of all members of the Board including Chairman, as well as election of David Kamenetzky as new Board member For the first time the AGM elects members of the Nomination and Compensation Committee and independent proxy
Nettoumsatz wächst mit 8.5% (10.4% zu konstanten Wechselkursen) erneut stärker als der relevante Markt, was zu Marktanteilsgewinnen führtFortsetzung des zweistellig profitablen Wachstums mit einer Steigerung des Gewinns nach Steuern um 16.6% (20.0% zu konstanten Wechselkursen) auf CHF 214.1 Millionen – bereinigt um ausserordentlichen VeräusserungsgewinnBetriebsgewinn um 2.5% (5.9% zu konstanten Wechselkursen) auf CHF 282.2 Millionen gesteigert – bereinigt um ausserordentlichen VeräusserungsgewinnZusätzlicher Betriebsgewinn von CHF 27.6 Millionen aus der Veräusserung einer zum operativen Vermögen gehörenden Liegenschaft in MalaysiaAusgezeichneter Free-Cashflow-Zuwachs um 62.5% (36.4% zu konstanten Wechselkursen) auf CHF 409.4 MillionenErhöhung der ordentlichen Dividende um CHF 0.15 (18.8%) auf CHF 0.95 pro Aktie1Zusätzliche Sonderdividende von CHF 0.15 pro Aktie1, um Aktionäre am Erlös aus dem Liegenschaftsverkauf zu beteiligenDKSH veröffentlicht erstmals Dreijahresziel mit Fortsetzung des nachhaltig profitablen Wachstums
Net sales growth of 8.5% (10.4% at constant exchange rates) again higher than addressable market, resulting in market share gainsDouble-digit profitable growth, with profit after tax rising by 16.6% (20.0% at constant exchange rates) to CHF 214.1 million – excluding extraordinary income from divestmentOperating profit growth of 2.5% (5.9% at constant exchange rates) to CHF 282.2 million – excluding extraordinary income from divestmentAdditional profit of CHF 27.6 million from the sale of a property in Malaysia belonging to operating assetsExcellent free cash flow growth of 62.5% (36.4% at constant exchange rates) to CHF 409.4 millionIncrease of the ordinary dividend by CHF 0.15 (18.8%) to CHF 0.95 per share1Additional special dividend of CHF 0.15 per share1 enabling shareholders to participate in proceeds from sale of propertyFor the first time, DKSH publishes a three-year target with further sustainable profitable growth foreseen
The Board of Directors of DKSH will propose at the next ordinary Annual General Meeting held on April 15, 2014, the election of David Kamenetzky to the Board of Directors. David Kamenetzky is currently a member of Mars, Incorporated's global management team, responsible for Corporate Affairs and Strategic Initiatives.
DKSH, the leading Market Expansion Services provider with a focus on Asia, today announced the acquisition of The Glory Medicine Limited (Glory), one of the leading healthcare distributors in Macau, thereby strengthening its Greater China operations by adding a direct presence in Macau. With this move, DKSH is driving forward the ongoing consolidation of the rapidly growing, yet highly fragmented Market Expansion Services industry.
DKSH, der führende Dienstleister für Marktexpansion mit Schwerpunkt Asien, hat heute die Übernahme von The Glory Medicine Limited („Glory“) bekannt gegeben, einem führenden Healthcare-Distributor in Macau. Das Unternehmen etabliert dadurch eine direkte Präsenz in Macau und stärkt seine Präsenz in Greater China. Mit diesem Schritt treibt DKSH die kontinuierliche Konsolidierung der schnell wachsenden, jedoch stark fragmentierten Branche der Marktexpansionsdienstleister weiter voran.
Fortsetzung des nachhaltig profitablen WachstumsNettoumsatz steigt um 14.3% auf CHF 4.8 Milliarden und damit wiederum deutlich stärker als der MarktGewinn nach Steuern wächst überproportional um 30.8% auf CHF 104.9 MillionenAusgezeichneter Free Cashflow von CHF 170.8 MillionenPräsenz in Indonesien durch strategische Akquisition gestärktAusblick auf zweistelliges, profitables Wachstum bestätigt
Continued sustainable profitable growthNet sales increased by 14.3% to CHF 4.8 billion, growing significantly above the marketProfit after tax increased over proportionally by 30.8% to CHF 104.9 millionExcellent free cash flow of CHF 170.8 millionPresence in Indonesia strengthened with strategic acquisitionGuidance of double-digit profitable growth confirmed
DKSH hat mit dem Eintritt von Bruno Sidler als COO Anfang Februar 2013 das Führungsteam verstärkt, um die Umsetzung der Wachstumsstrategie nachhaltig zu unterstützen. Nach seiner erfolgreichen Einarbeitung rapportieren nunmehr die operativen Leiter der vier Geschäftseinheiten Konsumgüter, Pharma, Spezialrohstoffe und Technologie an Bruno Sidler, der wiederum an den CEO Jörg Wolle berichtet.
With the entry of Bruno Sidler as COO at the beginning of February 2013, DKSH has strengthened its management team in order to support the implementation of its strategy for sustainable, profitable growth. After his successful introduction, the operational heads of the four Business Units Consumer Goods, Healthcare, Performance Materials and Technology now report to Bruno Sidler, who in turn reports to the CEO, Joerg Wolle.
DKSH (SIX: DKSH), the leading Market Expansion Services provider with a focus on Asia, announced today that a number of DKSH's strategic shareholders as well as members of the DKSH management team have successfully sold a total of 4 million registered shares of DKSH Holding AG through an accelerated bookbuilding, which took place overnight.
DKSH (SIX: DKSH), der führende Dienstleister für Marktexpansion mit Schwerpunkt Asien, gab heute bekannt, dass eine Reihe von strategischen Investoren sowie Mitglieder des DKSH-Managements über Nacht erfolgreich 4 Millionen DKSHAktien im Rahmen eines beschleunigten Bookbuilding-Verfahrens verkauft haben.
Jahresbericht, Jahresrechnung und Konzernrechnung für das Geschäftsjahr 2012 genehmigtZustimmung zur ordentlichen Dividende und zur Sonderdividende in der Gesamthöhe von CHF 0.95 pro AktieAlle Verwaltungsräte wiedergewähltStatutenänderungen gutgeheissen
Annual Report, annual financial statements and consolidated financial statements for the financial year 2012 approvedOrdinary and extraordinary dividend of in total CHF 0.95 per share resolvedAll Directors re-electedAmendments to the articles of association confirmed
Sustainable profitable growth continued in 2012 with a profit after tax increase of 21.3% to CHF 184.7 million – excluding extraordinary incomeNet sales expanded by CHF 1.5 billion (+20.4%) to CHF 8.8 billion, growing at more than double the speed of the marketsAt the same time DKSH generated free cash flow of CHF 249.5 millionAn ordinary dividend of CHF 0.80 (CHF +0.15 compared to prior year) per share and an additional extraordinary dividend of CHF 0.15 from divestment of non-core activity to be proposed at the AGM in April 2013Good start into 2013 – another record year with double-digit EBIT growth anticipated
Mit einem Wachstum des Gewinns nach Steuern von 21.3% auf CHF 184.7 Millionen setzt DKSH ihr nachhaltig profitables Wachstum gezielt fort (bereinigt um ausserordentlichen Veräusserungsgewinn)Nettoumsatz steigt um CHF 1.5 Milliarden (+20.4%) auf CHF 8.8 Milliarden und entwickelt sich damit mehr als doppelt so schnell wie der MarktGleichzeitig generiert DKSH einen Free Cashflow von CHF 249.5 MillionenDie ordentliche Dividende von CHF 0.80 (CHF +0.15 gegenüber Vorjahr) pro Aktie soll um eine Sonderdividende von CHF 0.15 pro Aktie aufgestockt werden, um die Aktionäre am ausserordentlichen Gewinn aus der Veräusserung eines nicht strategischen Geschäftsfeldes teilhaben zu lassen – so der Antrag an die Generalversammlung im April 2013Guter Jahresauftakt 2013 lässt neues Rekordjahr mit zweistelligem EBIT-Wachstum erwarten
DKSH, der führende Dienstleister für Marktexpansion in Asien, übernimmt Miraecare, eines der führenden Distributions- und Dienstleistungsunternehmen für Medizinaltechnik in Korea und stärkt so nebst seines Koreageschäfts auch die Präsenz und Expertise seiner Geschäftseinheit Healthcare in der Medizinaltechnik-Branche. Mit diesem Schritt treibt DKSH die kontinuierliche Konsolidierung der schnell wachsenden, jedoch stark fragmentierten Branche der Marktexpansionsdienstleister weiter voran.
DKSH, the leading Market Expansion Services provider with a focus on Asia, acquires Miraecare, one of the leading medical device distribution and service providers in Korea, thereby strengthening its Korean operations as well as footprint and capabilities of its Business Unit Healthcare in the medical device industry. With this move, DKSH is driving forward the ongoing consolidation of the rapidly growing, yet highly fragmented Market Expansion Services industry.
DKSH, der führende Dienstleister für Marktexpansion in Asien, übernimmt den Schweizer Spezialchemikalien-Distributor Staerkle & Nagler AG und stärkt damit in Ergänzung seiner Marktführerposition in Asien das Europageschäft der Geschäftseinheit Spezialrohstoffe. Mit diesem Schritt treibt DKSH die kontinuierliche Konsolidierung der schnell wachsenden, jedoch stark fragmentierten Branche der Marktexpansionsdienstleister weiter voran.
DKSH, the leading Market Expansion Services provider with a focus on Asia, has acquired the Swiss specialty chemicals distributor Staerkle & Nagler, thereby complementing its market leadership in Asia by strengthening the European operations of its Business Unit Performance Materials. With this move, DKSH is driving forward the ongoing consolidation of the rapidly growing, yet highly fragmented Market Expansion Services industry.
The Board of Directors of DKSH, the leading Market Expansion Services provider with a focus on Asia, has extended the contract with President & CEO, Dr. Joerg Wolle, for a further five years term. Given the uninterrupted profitable growth pattern and considerable expansion opportunities in Asia, DKSH has further strengthened its management structure by appointing Bruno Sidler as Chief Operating Officer.
Der Verwaltungsrat von DKSH, dem führenden Dienstleister für Marktexpansion mit Schwerpunkt Asien, verlängert den Vertrag mit dem CEO und Delegierten des Verwaltungsrats, Dr. Jörg Wolle, um weitere fünf Jahre. Weiter verstärkt DKSH aufgrund des nachhaltig profitablen Wachstums und der grossen Expansionsmöglichkeiten in Asien ihre Führungsstruktur mit der Berufung von Bruno Sidler zum Chief Operating Officer.
Subsequent to the settlement of a long-term performance-based share plan in conjunction with the IPO and the end of the lock-up period for management, members of DKSH Group's senior management have sold a portion of the performance shares to cover personal tax obligations.
Nach der Auflösung eines langfristigen Performance Share Planes im Zusammenhang mit dem IPO sowie dem Ablauf der Verkaufssperre (Lock-up) für das Management haben Mitglieder des oberen Führungskreises der DKSH Gruppe einen Anteil der Performance-Aktien verkauft, um ihren persönlichen Steuerpflichten nachzukommen.
Fortsetzung des nachhaltig profitablen Wachstums mit EBITSteigerung um 23.0% auf CHF 127 MillionenGewinn nach Steuern um 23.6% auf CHF 81 Millionen erhöhtNettoumsatz wächst 16.0% auf CHF 4.2 Milliarden und damit wiederum deutlich stärker als der MarktPositiver Ausblick bestätigt
Continues track record of sustainable profitable growth with EBIT increasing by 23.0% to CHF 127 millionProfit after tax increased by 23.6% to CHF 81 millionNet sales increased by 16.0% to CHF 4.2 billion, growing significantly above the marketPositive outlook confirmed
DKSH, the leading Market Expansion Services Group with a focus on Asia, takes over the old-established German-Japanese trading company Clay and Company Limited (Clay). With this acquisition, DKSH strengthens its leading position in Asia and expands its capital investment goods and lifestyle business in Japan.
DKSH, der führende Dienstleister für Marktexpansion in Asien, übernimmt die traditionsreiche deutsch-japanische Handelsfirma Clay and Company Limited (Clay). Damit untermauert DKSH ihre Führungsposition in Asien und baut ihr Investitionsgüter- und Lifestylegeschäft in Japan gezielt aus.
DKSH Holding AG (DKSH), führender Dienstleister für Marktexpansion in Asien, hat heute seine Finanzzahlen für das erste Halbjahr 2011 veröffentlicht, die den historischen Kontext für die bevorstehenden Halbjahresresultate bilden.
DKSH Holding Ltd. (DKSH), the leading Market Expansion Services provider with a focus on Asia, has today published key financial statements of its 2011 half-year results to provide historical context for half-year performance.
DKSH Holding Ltd. (DKSH), the leading Market Expansion Services provider with a focus on Asia(1), announces today that the Joint Bookrunners, acting on behalf of the syndicate banks, have fully exercised the over-allotment (Greenshoe) option of 10% of the shares offered in the base offer at the offering price of CHF 48 per share.
DKSH Holding AG (DKSH), führender Dienstleister für Marktexpansion in Asien(1), gibt heute bekannt, dass die Joint Bookrunners im Namen des Bankensyndikats die Mehrzuteilungsoption (Greenshoe) von 10% des Basisangebots zum Angebotspreis von CHF 48 je Aktie vollständig ausgeübt hat.
DKSH Holding AG (DKSH), führender Dienstleister für Marktexpansion in Asien(1), platziert im Rahmen des IPO 17,107,102 Aktien zum Preis von CHF 48 pro Aktie. Erster Handelstag an der SIX Swiss Exchange ist heute, Dienstag.
DKSH Holding Ltd. (DKSH), the leading Market Expansion Services provider with a focus on Asia*, placed 17,107,102 shares at the price of CHF 48 per share for its Initial Public Offering (IPO). Today, Tuesday, is the first day of trading of its shares on SIX Swiss Exchange.
DKSH Holding AG (DKSH), führender Dienstleister für Marktexpansion in Asien(1), gibt bekannt, dass heute im Rahmen eines Initial Public Offering (IPO) der Gang an die SIX Swiss Exchange eingeleitet und das Bookbuilding gestartet wird. Die Diethelm Keller Holding und weitere strategische Aktionäre werden einen Teil ihrer DKSH-Beteiligung veräussern. Diethelm Keller Holding wird als Ankeraktionärin weiterhin massgeblich an der Gruppe beteiligt bleiben und so die Kontinuität im Aktionariat sicherstellen. Einer ersten Erweiterung auf private, familienferne Grossaktionäre im Jahr 2008 folgt damit die Öffnung gegenüber dem breiten Publikum. Der Börsengang hat einerseits zum Ziel, den Wechsel zur fünften Familiengeneration beim Mehrheitsaktionär, der Zürcher Diethelm Keller Holding, durch eine strukturierte Diversifikation des Investmentportfolios zu unterstützen und andererseits, den Bekanntheitsgrad von DKSH bei potentiellen Herstellern und Kunden, sowie im Markt für talentierte Fachkräfte nachhaltig zu erhöhen. DKSH veröffentlicht heute die Einzelheiten des geplanten IPO an der SIX Swiss Exchange.
DKSH Holding Ltd. (DKSH), the leading Market Expansion Services provider with a focus on Asia*, announces today that it is initiating the launch of its Initial Public Offering (IPO) on the SIX Swiss Exchange, and the start of book building. Diethelm Keller Holding and other strategic shareholders will be divesting a portion of their DKSH shares. As an anchor shareholder, Diethelm Keller Holding will continue retaining a significant stake in the Group, thereby ensuring continuity within the shareholding structure. This opening up to the wider public follows an initial broadening of the shareholder base to include private, non-family strategic investors in 2008. The objectives of the IPO are on the one hand to allow its majority shareholder, Diethelm Keller Holding, to diversify its investment portfolio in a structured manner to support the transition to the fifth generation of the founding families. On the other hand, it will help DKSH enhance the level of DKSH brand recognition among existing and potential clients and customers, as well as in the recruitment market for professionals and top talent. Today, DKSH is publishing the transaction details of its planned IPO on the SIX Swiss Exchange.
歡迎聯繫我們，探索更多合作機會。